An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1, 4‐di‐ N ‐oxide scaffold
Publication type: Journal Article
Publication date: 2022-06-01
scimago Q2
wos Q2
SJR: 0.689
CiteScore: 5.6
Impact factor: 3.3
ISSN: 17470277, 17470285
PubMed ID:
35610776
Organic Chemistry
Drug Discovery
Biochemistry
Pharmacology
Molecular Medicine
Abstract
Quinoxaline 1,4-di-N-oxides (QdNOs) exhibit multifaceted biological properties, wherein antimicrobial, anticancer, antitrypanosomal, and anti-inflammatory properties are included. Because of their various activities in clinical practice and research, they have a wide spectrum of uses and possibilities. QdNOs have received a significant amount of attention, and research into their medicinal chemistry is still a part of experimental investigation and analytical studies. In this review, QdNOs are classified depending on their actions, which include antibacterial and anti-mycobacterial, anticancer or antitumor, antimalarial, antifungal, and other activities. In a conclusion, it's important to base the development of novel synthetic techniques and the design of new QdNO derivatives on the most up-to-date knowledge gleaned from recent research. With the summarised structure-activity relationship of fascinating QdNOs, this review aims to provide insights into the developments in the chemistry and biological activity of QdNO derivatives.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
|
|
|
Letters in Organic Chemistry
2 publications, 22.22%
|
|
|
Compounds
1 publication, 11.11%
|
|
|
European Journal of Medicinal Chemistry
1 publication, 11.11%
|
|
|
ChemistrySelect
1 publication, 11.11%
|
|
|
Pharmaceuticals
1 publication, 11.11%
|
|
|
Archiv der Pharmazie
1 publication, 11.11%
|
|
|
Medicinal Chemistry
1 publication, 11.11%
|
|
|
Mendeleev Communications
1 publication, 11.11%
|
|
|
1
2
|
Publishers
|
1
2
3
|
|
|
Bentham Science Publishers Ltd.
3 publications, 33.33%
|
|
|
MDPI
2 publications, 22.22%
|
|
|
Wiley
2 publications, 22.22%
|
|
|
Elsevier
1 publication, 11.11%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 11.11%
|
|
|
1
2
3
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
9
Total citations:
9
Citations from 2025:
1
(11.11%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Agrawal N., Bhardwaj A. An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1, 4‐di‐ N ‐oxide scaffold // Chemical Biology and Drug Design. 2022. Vol. 100. No. 3. pp. 346-363.
GOST all authors (up to 50)
Copy
Agrawal N., Bhardwaj A. An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1, 4‐di‐ N ‐oxide scaffold // Chemical Biology and Drug Design. 2022. Vol. 100. No. 3. pp. 346-363.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1111/cbdd.14094
UR - https://doi.org/10.1111/cbdd.14094
TI - An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1, 4‐di‐ N ‐oxide scaffold
T2 - Chemical Biology and Drug Design
AU - Agrawal, Neetu
AU - Bhardwaj, Aditya
PY - 2022
DA - 2022/06/01
PB - Wiley
SP - 346-363
IS - 3
VL - 100
PMID - 35610776
SN - 1747-0277
SN - 1747-0285
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2022_Agrawal,
author = {Neetu Agrawal and Aditya Bhardwaj},
title = {An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1, 4‐di‐ N ‐oxide scaffold},
journal = {Chemical Biology and Drug Design},
year = {2022},
volume = {100},
publisher = {Wiley},
month = {jun},
url = {https://doi.org/10.1111/cbdd.14094},
number = {3},
pages = {346--363},
doi = {10.1111/cbdd.14094}
}
Cite this
MLA
Copy
Agrawal, Neetu, and Aditya Bhardwaj. “An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1, 4‐di‐ N ‐oxide scaffold.” Chemical Biology and Drug Design, vol. 100, no. 3, Jun. 2022, pp. 346-363. https://doi.org/10.1111/cbdd.14094.